BMS-986449
- Generic Name
- BMS-986449
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 100
- Registration Number
- NCT05888831
- Locations
- 🇫🇷
Institut Bergonie Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest, Bordeaux, France
🇮🇹Local Institution - 0023, Rozzano, Milano, Italy
🇮🇹Local Institution - 0024, Siena, Toscana, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath